Evidence of interstitial lung disease or active, non-infectious pneumonitis
Has evidence of interstitial lung disease or active, non-infectious pneumonitis
History of interstitial lung disease or non-infectious pneumonia.
The subject has any history or evidence of active, non-infectious pneumonitis or interstitial lung disease
SAFETY RUN-IN: Has evidence of interstitial lung disease or active, non-infectious pneumonitis
RANDOMIZED PHASE II CLINICAL TRIAL: Has evidence of interstitial lung disease or active, non-infectious pneumonitis
Has history of interstitial lung disease or non-infectious pneumonitis except for those induced by radiation therapies.
Known non-infectious pneumonitis or any history of interstitial lung disease
The participant has any history or evidence of active, non-infectious pneumonitis or interstitial lung disease
Evidence of interstitial lung disease or active, non-infectious pneumonitis
EXCLUSION - DURVALUMAB DRUG-SPECIFIC: Participant has evidence of interstitial lung disease or active non-infectious pneumonitis.
Evidence of interstitial lung disease or active, non-infectious pneumonitis
Has known history of, or any evidence of active, interstitial lung disease or non-infectious pneumonitis requiring corticosteroid therapy
Patients with evidence of interstitial lung disease or active, non-infectious pneumonitis; patients with a history of interstitial lung disease or non-infectious pneumonitis requiring treatment with steroids are also excluded
Patients with evidence of non-infectious pneumonitis or history of interstitial lung disease
Evidence of active interstitial lung disease or active non-infectious pneumonitis
Has a known history of, or any evidence of, interstitial lung disease or active non- infectious pneumonitis
Have evidence of interstitial lung disease or active, non-infectious pneumonitis
Previous clinical diagnosis of non-infectious pneumonitis or non-infectious interstitial lung disease
History of (non-infectious) pneumonitis requiring treatment with corticosteroids, evidence of interstitial lung disease or active, non-infectious pneumonitis
Evidence of interstitial lung disease or active, non-infectious pneumonitis
Known history or evidence of interstitial lung disease or active, non-infectious pneumonitis
Significant pulmonary disease, including pulmonary hypertension, interstitial lung disease, or active, non-infectious pneumonitis
Has evidence of interstitial lung disease or active, non-infectious pneumonitis
Has evidence of interstitial lung disease or active, non-infectious pneumonitis
Evidence of interstitial lung disease or active, non-infectious pneumonitis
Evidence of interstitial lung disease or active non-infectious pneumonitis
Has evidence of interstitial lung disease or active, non-infectious pneumonitis
Subject has evidence of interstitial lung disease or active, non-infectious pneumonitis
Has evidence of interstitial lung disease or active, non-infectious pneumonitis
Has evidence of interstitial lung disease or active, non-infectious pneumonitis that required oral or intravenous glucocorticoids to assist with management; lymphangitic spread of the non-small cell lung cancer (NSCLC) is not exclusionary
Has evidence of interstitial lung disease or active, non-infectious pneumonitis
Evidence of pre-existing interstitial lung disease or active, non-infectious pneumonitis
Has evidence of interstitial lung disease or active, non-infectious pneumonitis
History of interstitial lung disease or non-infectious pneumonitis, unless induced by radiation therapy
Has evidence of interstitial lung disease, active, non-infectious pneumonitis
History of or active, non-infectious pneumonitis and/or a history of interstitial lung disease
Patients with evidence of interstitial lung disease or active, non-infectious pneumonitis
Has evidence of interstitial lung disease or active, non-infectious pneumonitis
Has evidence of interstitial lung disease, active non-infectious pneumonitis, or a history of grade  or greater pneumonitis
Known history of, or any evidence of interstitial lung disease or active, non-infectious pneumonitis
History or evidence of active, non-infectious pneumonitis or interstitial lung disease
Evidence of active non-infectious pneumonitis/interstitial lung disease
Has evidence of interstitial lung disease or active, non-infectious pneumonitis
Has interstitial lung disease or active, non-infectious pneumonitis
Has history of interstitial lung disease or non-infectious pneumonitis except for those induced by radiation therapies..
Has evidence of interstitial lung disease or active, non-infectious pneumonitis
Has evidence of interstitial lung disease or active, non-infectious pneumonitis
Has evidence of interstitial lung disease or active, non-infectious pneumonitis
Has evidence of interstitial lung disease or active, non-infectious pneumonitis
Has evidence of interstitial lung disease, any active, non-infectious pneumonitis, or known active tuberculosis
Has evidence of interstitial lung disease or active, non-infectious pneumonitis
Has evidence of interstitial lung disease or active, non-infectious pneumonitis
Has evidence of interstitial lung disease or active, non-infectious pneumonitis
Has evidence of interstitial lung disease or active, non-infectious pneumonitis
Evidence of interstitial lung disease or active non-infectious pneumonitis
Has evidence of interstitial lung disease or active, non-infectious pneumonitis
Evidence of interstitial lung disease or active non-infectious pneumonitis
Has evidence of interstitial lung disease or active, non-infectious pneumonitis.
Has evidence of interstitial lung disease or active, non-infectious pneumonitis
Previous clinical diagnosis of non-infectious pneumonitis or non-infectious interstitial lung disease
Has evidence of interstitial lung disease or active, non-infectious pneumonitis
Has evidence of interstitial lung disease or active, non-infectious pneumonitis; has an active infection requiring systemic therapy
Has clinical or radiologic evidence of interstitial lung disease or active, non-infectious pneumonitis